BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/7/2015 6:08:00 PM | Browse: 296 | Download: 363
Publication Name World Journal of Gastroenterology
Manuscript ID 15379
Country of Manuscript Source South Korea
2014-11-24 19:26
Peer-Review Started
2014-11-25 10:39
To Make the First Decision
2014-12-26 13:24
Return for Revision
2014-12-31 09:07
2015-01-02 14:04
Second Decision
2015-01-31 09:27
Accepted by Journal Editor-in-Chief
2015-01-31 18:32
Accepted by Company Editor-in-Chief
2015-02-05 17:09
Articles in Press
2015-02-05 17:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
2015-02-08 18:55
Typeset the Manuscript
2015-03-23 11:24
Publish the Manuscript Online
2015-04-07 17:13
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Review
Article Title Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Myeong Jun Song
Funding Agency and Grant Number
Correspondence To Myeong Jun Song, MD, PhD, Division of Hepatology, Department of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, the Catholic University of Korea, Daeheung-ro 64, Jung-gu, Daejeon 301-723, South Korea. mjsong95@gmail.com
Keywords Hepatocellular carcinoma; Advanced stage hepatocellular carcinoma; Sorafenib; Hepatic arterial infusion chemotherapy; Treatment efficacy
Core Tip Sorafenib is the standard of treatment for advanced hepatocellular carcinoma (HCC). However, the suitability of sorafenib is limited by its low response rates, and unsuitability for patients with poor liver function. Therefore, other treatment modalities are required. Hepatic arterial infusion chemotherapy (HAIC) has the advantages of delivering high levels of chemotherapeutic drugs directly into tumor-associated hepatic arterial branches and repeat injections are relatively simple to carry out. Thus the local therapeutic level is increased and systemic adverse effects are decreased. In the future, HAIC may be a promising treatment strategy for the management of advanced HCC.
Publish Date 2015-04-07 17:13
Citation Song MJ. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3843-3849
Url http://www.wjgnet.com/1007-9327/full/v21/i13/3843.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i13.3843
Full Article (PDF) WJG-21-3843.pdf
Full Article (Word) WJG-21-3843.doc
Revised Manuscript 15379-Review.doc
Peer-review Report 15379-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 15379-Journal Editor-in-Chief's Review Report.pdf
Answering Reviewers 15379-Answering reviewers.pdf
Scientific Misconduct Check 15379-Scientific misconduct check.pdf
Scientific Editor Work List 15379-Scientific editor work list.pdf
Conflict-of-Interest Disclosure Form 15379-Conflict-of-interest statement.pdf
Copyright License Agreement 15379-Conflict-of-interest statement.pdf